Quantification of active infliximab in human serum with liquid chromatography–tandem mass spectrometry using a tumor necrosis factor alpha -based pre-analytical sample purification and a stable isotopic labeled infliximab bio-similar as internal standard: A target-based, sensitive and cost-effective method

Autor: El Amrani, Mohsin, van den Broek, Marcel P.H., Göbel, Camiel, van Maarseveen, Erik M.
Zdroj: In Journal of Chromatography A 8 July 2016 1454:42-48
Databáze: ScienceDirect